BeiGene, Ltd. - Sep 24, 2021 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Role
10%+ Owner
Signature
BeiGene, Ltd. /s/ Scott A. Samuels, SVP, General Counsel
Stock symbol
LPTX
Transactions as of
Sep 24, 2021
Transactions value $
$7,249,830
Form type
4
Date filed
9/28/2021, 05:48 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LPTX Common Stock Purchase $7.25M +2.54M +52.94% $2.85 7.35M Sep 24, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 24, 2021, BeiGene, Ltd. purchased 2,543,800 shares of common stock of the Issuer for $2.85 per share pursuant to an underwritten public offering.